Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Jun;25(6):518–520. doi: 10.1136/jcp.25.6.518

Clinical pharmacology of cephalexin administered by intravenous injection

J A Davies 1, J M Holt 1
PMCID: PMC477369  PMID: 5043377

Abstract

Cephalexin IG was given by intravenous injection to eight normal volunteers, five patients with chronic renal failure, and three patients during a period of haemodialysis. In normal subjects there was a rapid fall in serum concentration and 80% of the administered dose was excreted in the urine within two hours. The mean serum half life was 1·1 hours (range 0·6-1·8 hours). Prior treatment with probenecid in two subjects led to a twofold increase in serum concentration two hours after injection. In the patients with chronic renal failure antimicrobial activity persisted for 24 hours and the half life ranged from 6·1 to 18·1 hours. Haemodialysis led to partial removal of cephalexin from the blood, but antimicrobial activity remained eight hours after injection at the end of the dialysis period. The serum half life in these patients was 5·1, 5·6, and 5·7 hours.

Full text

PDF
518

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. De Maine J. B., Kirby W. M. Clinical pharmacology of cephalexin administered intravenously. Antimicrob Agents Chemother (Bethesda) 1970;10:190–194. [PubMed] [Google Scholar]
  3. Gower P. E., Dash C. H. Cephalexin: human studies of absorption and excretion of a new cephalosporin antibiotic. Br J Pharmacol. 1969 Nov;37(3):738–747. doi: 10.1111/j.1476-5381.1969.tb08513.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. KUNIN C. M., FINLAND M. Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity. N Engl J Med. 1958 Nov 20;259(21):999–1005. doi: 10.1056/NEJM195811202592102. [DOI] [PubMed] [Google Scholar]
  5. Kabins S. A., Kelner B., Walton E., Goldstein E. Cephalexin therapy as related to renal function. Am J Med Sci. 1970 Feb;259(2):133–142. doi: 10.1097/00000441-197002000-00007. [DOI] [PubMed] [Google Scholar]
  6. Kunin C. M., Finkelberg Z. Oral cephalexin and ampicillin: antimicrobial activity, recovery in urine, and persistence in blood of uremic patients. Ann Intern Med. 1970 Mar;72(3):349–356. doi: 10.7326/0003-4819-72-3-349. [DOI] [PubMed] [Google Scholar]
  7. Wick W. E. Cephalexin, a new orally absorbed cephalosporin antibiotic. Appl Microbiol. 1967 Jul;15(4):765–769. doi: 10.1128/am.15.4.765-769.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES